ArticleScientific reports2025
Quantum chimp-enanced SqueezeNet for precise diabetic retinopathy classification.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Decision-Flux Optimization-based energy management for battery-supercapacitor hybrid storage in electric vehicles: battery lifetime and efficiency enhancement.Scientific reports · 2026Article
- Hybrid quantum-classical deep learning framework for balanced multiclass diabetic retinopathy classification.MethodsX · 2025Article
- Multi-task deep learning framework combining CNN: vision transformers and PSO for accurate diabetic retinopathy diagnosis and lesion localization.Scientific reports · 2025Article
- Explainable artificial intelligence driven insights into smoking prediction using machine learning and clinical parameters.Scientific reports · 2025Article
- The immune-related plasma protein LAT2 as a protective modulator in diabetic retinopathy: a Mendelian randomization study.Frontiers in endocrinology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Diabetic retinopathy remains a prominent cause of blindness throughout the world, and it is a product of prolonged high blood sugar levels that degrade the retinal blood vessels. This makes early detection of DR critical to stop irreversible blindness from occurring. This paper presents an advanced hybrid approach that utilizes the Quantum Chimp Optimization Algorithm (QCOA) integrated with SqueezeNet to enhance the accuracy and efficiency of DR classification significantly. The novel methodology was divided into two main stages: feature extraction and classification. Firstly, SqueezeNet enables efficient feature extraction from segmented fundus images with minimal computational complexity, ensuring that critical retinal features are captured effectively. The classification process, QCOA optimizes the Support Vector Machine (SVM) parameters and performs feature selection. The hybrid system effectively refines the performance of the SVM, consequently increasing the classification accuracies and optimizing the model's performance. By leveraging QCOA's capability to tune SVM parameters precisely, the proposed approach achieves remarkable classification accuracy, sensitivity, and specificity rates of 99.80%, 99.90%, and 100%, respectively. Fundamentally, the results display the efficiency and practical utility of the proposed approach, and its implementation in real-world clinical settings is likely to significantly improve the rates of early DR reflection and accurate classification for improved patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.